These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7949468)

  • 1. Correlation between immune and vascular activities of xanthenone acetic acid antitumor agents.
    Zwi LJ; Baguley BC; Gavin JB; Wilson WR
    Oncol Res; 1994; 6(2):79-85. PubMed ID: 7949468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthenone-4-acetic acid.
    Thomsen LL; Ching LM; Baguley BC
    Cancer Res; 1990 Nov; 50(21):6966-70. PubMed ID: 2170013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-dependent increased plasma nitrate concentrations as an indication of the antitumor effect of flavone-8-acetic acid and analogues in mice.
    Thomsen LL; Ching LM; Zhuang L; Gavin JB; Baguley BC
    Cancer Res; 1991 Jan; 51(1):77-81. PubMed ID: 1988109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of immune effector cells in flavone acetic acid-induced injury to tumor cells in EMT6 spheroids.
    Zwi LJ; Baguley BC; Gavin JB; Holdaway KM; Wilson WR
    Oncol Res; 1992; 4(8-9):333-9. PubMed ID: 1486217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: relation to vascular effects.
    Baguley BC; Zhuang L; Kestell P
    Oncol Res; 1997; 9(2):55-60. PubMed ID: 9167186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-modulating and anti-vascular activities of two xanthenone acetic acid analogues: A comparative study to DMXAA.
    Barbera M; Kettunen MI; Caputo A; Hu DE; Gobbi S; Brindle KM; Carrara M
    Int J Oncol; 2009 Jan; 34(1):273-9. PubMed ID: 19082498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine induction and therapeutic synergy with interleukin-2 against murine renal and colon cancers by xanthenone-4-acetic acid derivatives.
    Futami H; Eader L; Back TT; Gruys E; Young HA; Wiltrout RH; Baguley BC
    J Immunother (1991); 1992 Nov; 12(4):247-55. PubMed ID: 1477076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of natural killer activity by xanthenone analogues of flavone acetic acid: relation with antitumour activity.
    Ching LM; Joseph WR; Zhuang L; Atwell GJ; Rewcastle GW; Denny WA; Baguley BC
    Eur J Cancer; 1991; 27(1):79-83. PubMed ID: 1826446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown.
    Mahadevan V; Malik ST; Meager A; Fiers W; Lewis GP; Hart IR
    Cancer Res; 1990 Sep; 50(17):5537-42. PubMed ID: 2386959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide production in endotoxin-resistant C3H/HeJ mice stimulated with flavone-8-acetic acid and xanthenone-4-acetic acid analogues.
    Thomsen LL; Ching LM; Joseph WR; Baguley BC; Gavin JB
    Biochem Pharmacol; 1992 Jun; 43(11):2401-6. PubMed ID: 1610403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro methods for screening agents with an indirect mechanism of antitumour activity: xanthenone analogues of flavone acetic acid.
    Ching LM; Finlay GJ; Joseph WR; Baguley BC
    Eur J Cancer; 1991; 27(12):1684-9. PubMed ID: 1782083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships for substituted 9-oxo-9,10-dihydroacridine-4-acetic acids: analogues of the colon tumour active agent xanthenone-4-acetic acid.
    Gamage SA; Rewcastle GW; Atwell GJ; Baguley BC; Denny WA
    Anticancer Drug Des; 1992 Oct; 7(5):403-14. PubMed ID: 1388631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ability of coumarin-, flavanon- and flavonol-analogues of flavone acetic acid to stimulate human monocytes.
    Barbera M; Caputo A; Zampiron A; Gobbi S; Rampa A; Bisi A; Carrara M
    Oncol Rep; 2008 Jan; 19(1):187-96. PubMed ID: 18097594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).
    Ching LM; Joseph WR; Crosier KE; Baguley BC
    Cancer Res; 1994 Feb; 54(4):870-2. PubMed ID: 8313372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mono- or di-fluorinated analogues of flavone-8-acetic acid: synthesis and in vitro biological activity.
    Carrara M; Zampiron A; Barbera M; Caputo A; Bisi A; Gobbi S; Belluti F; Piazzi L; Rampa A; Valenti P
    Anticancer Res; 2005; 25(2A):1179-85. PubMed ID: 15868960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule cytokine inducers causing tumor necrosis.
    Baguley BC
    Curr Opin Investig Drugs; 2001 Jul; 2(7):967-75. PubMed ID: 11757800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haematological effects in mice of the antitumour agents xanthenone-4-acetic acid, 5,6-dimethyl-xanthenone-4-acetic acid [correction of 5,6-methyl-] and flavone acetic acid.
    Ching LM; McKeage MJ; Joseph WR; Kestell P; Zwi LJ; Baguley BC
    Cancer Chemother Pharmacol; 1991; 28(6):414-9. PubMed ID: 1934245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in coagulation and permeability properties of human endothelial cells in vitro induced by TNF-alpha or 5,6 MeXAA.
    Watts ME; Arnold S; Chaplin DJ
    Br J Cancer Suppl; 1996 Jul; 27():S164-7. PubMed ID: 8763872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of the novel antitumour agent xanthenone-4-acetic acid in the mouse: identification of metabolites and routes of elimination.
    Kestell P; Rewcastle GW; Baguley BC
    Xenobiotica; 1994 Jul; 24(7):635-47. PubMed ID: 7975728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the ability of DMXAA and xanthenone analogues to activate NF-kappaB in murine and human cell lines.
    Woon ST; Reddy CB; Drummond CJ; Schooltink MA; Baguley BC; Kieda C; Ching LM
    Oncol Res; 2005; 15(7-8):351-64. PubMed ID: 16491953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.